PubMed: Potential therapeutic uses of cannabinoids to treat behavioural problems in children and adolescents with developmental disorders
Aust J Gen Pract. 2021 Jun;50(6):352-355. doi: 10.31128/AJGP-01-21-5809.
BACKGROUND: There is a great deal of interest in the potential symptomatic benefits of medicinal cannabis among parents of children and adolescents with developmental disorders.
OBJECTIVE: This article provides an overview of what is known about medicinal cannabis as a treatment for paediatric developmental disorders.
DISCUSSION: While there is emerging evidence in support of medicinal cannabis for some adult mental health disorders, to date the evidence in children and adolescents is scant. Reports from uncontrolled observational studies suggest that cannabidiol-rich products may be helpful in reducing behavioural problems in autistic youth. Cannabidiol appears to have a relatively benign adverse effect profile and therefore may be worth considering as a treatment option in some cases. Several controlled clinical trials are underway that will provide more definitive information on the therapeutic value of medicinal cannabis in paediatric developmental and behavioural disorders.
#CBD #Hemp https://pubmed.ncbi.nlm.nih.gov/34059838/?utm_source=WordPress&utm_medium=rss&utm_campaign=None&utm_content=1jYCQzi_o_qLYr-oQfnMhShgOXkvGma3vcnBGJtrBhuJMOvEVJ&fc=None&ff=20210602070011&v=2.14.4 June 1, 2021 10:00 am